Boteng: net profit in the first half of the year increased by 60% - 70% year on year
According to the announcement of Boteng, the net profit in the first half of 2021 is expected to be 210 million yuan – 223 million yuan, with a year-on-year growth of 60% - 70%. Under the background of steady growth of global pharmaceutical R & D pipeline and increasing trend of pharmaceutical R & D outsourcing, the company has continuously consolidated the achievements of cdmo strategic transformation, continuously expanded and enriched product pipeline, continuously improved technical capability and product delivery capability, and continuously improved the company's ability to obtain orders. In the first half of 2021, the company expects to achieve a 30% - 40% increase in operating revenue compared with the same period last year.
This text is a result of machine translation.
Related companies：
Briefing May 19, 2022 11:34 AM
· Financials
The index recovered, and the gem index and Shanghai index once turned red
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
“We thought this battle would be over in one or two years, but it has been dragging on for three years, so this could conversely be an opportunity for us to focus on; in other words, amid the unexpected international and domestic situation, new opportunities will be seen.”
Updated 29 mins ago
Briefing Mar 13, 2022 04:38 PM
Dongfang Yuhong: adjust the prices of some main products of the company, among which the asphalt coiled material is increased by 15% - 20%.
May 02, 2022 07:50 PM
Apr 28, 2022 08:00 PM
Apr 26, 2022 12:26 PM
Apr 25, 2022 01:02 PM
Donghua Technology: pre winning the EPC project of ammonium dihydrogen phosphate project for battery
Market shock consolidation, public offering and private placement increased positions simultaneously
Briefing Dec 20, 2021 08:58 AM
Bufeng international calls out the list of Hong Kong stocks under Shenzhen Hong Kong stock connect
See more
Read next
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
Updated 29 mins ago
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.